MSI-H tumor responds to immunotherapy while MSI-stable tumor does not in same patient Skip to content The CRC Digest MSI-H tumor responds to immunotherapy while MSI-stable tumor does not in same patient Exceptional case of synchronous colon cancers with different MMR status provides direct in vivo evidence of ICI responsiveness differences. (Japanese Journal of Clinical Oncology) This content is informational only and does